Login / Signup

Did the Randomized Phase III KEYNOTE-181 Study of Pembrolizumab for Esophageal Cancer Yield Negative or Positive Results?

Hironobu MinamiNaomi KiyotaTakashi Omori
Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
Keyphrases
  • phase iii
  • open label
  • phase ii
  • double blind
  • clinical trial
  • placebo controlled
  • randomized controlled trial
  • advanced non small cell lung cancer
  • study protocol
  • epidermal growth factor receptor